ScholarIQanswers from OpenAlex & ORCID
Aaron N. Hata
ResearcherPublications, citations & collaboration network
Aaron N. Hata is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Aaron N. Hata have?
ScholarIQindexed works
Aaron N. Hata has 522 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Aaron N. Hata have?
ScholarIQcitation count
Aaron N. Hata has 15,163 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Aaron N. Hata?
ScholarIQh-index
Aaron N. Hata has an h-index of 55 in OpenAlex.
What is the i10-index of Aaron N. Hata?
ScholarIQi10-index
Aaron N. Hata has an i10-index of 98 in OpenAlex.
What is the ORCID of Aaron N. Hata?
ScholarIQorcid
The ORCID for Aaron N. Hata is on the source record.
What is the OpenAlex record for Aaron N. Hata?
ScholarIQopenalex
The OpenAlex for Aaron N. Hata is on the source record.
What are the most-cited papers on Aaron N. Hata?
ScholarIQmost cited works
<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis
Justin F. Gainor, Alice T. Shaw, Lecia V. Sequist, Xiujun Fu, Christopher G. Azzoli, Zofia Piotrowska, Tiffany G. Huynh, Ling Zhao, Linnea Fulton, Katherine R. Schultz, Emily Howe, Anna F. Farago, Ryan J. Sullivan, James R. Stone, Subba R. Digumarthy, Teresa Morán, Aaron N. Hata, Yukako Yagi, Beow Y. Yeap, Jeffrey A. Engelman, Mari Mino–Kenudson
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
Aaron N. Hata, Matthew J. Niederst, Hannah L. Archibald, María Gomez‐Caraballo, Faria M. Siddiqui, Hillary E. Mulvey, Yosef E. Maruvka, Fei Ji, Hyo-Eun Carrie Bhang, Viveksagar Krishnamurthy Radhakrishna, Giulia Siravegna, Haichuan Hu, Sana Raoof, Elizabeth L. Lockerman, Anuj Kalsy, Dana Lee, Celina L Keating, David A. Ruddy, Leah J. Damon, Adam Crystal, Carlotta Costa, Zofia Piotrowska, Alberto Bardelli, A. John Iafrate, Ruslan I. Sadreyev, Frank Stegmeier, Gad Getz, Lecia V. Sequist, Anthony C. Faber, Jeffrey A. Engelman
Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation
Aaron N. Hata, Richard Breyer
A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors
Michal Slyper, Caroline Porter, Orr Ashenberg, Julia Waldman, Eugene Drokhlyansky, Isaac Wakiro, Christopher S. Smillie, Gabriela Smith-Rosario, Jingyi Wu, Danielle Dionne, Sébastien Vigneau, Judit Jané‐Valbuena, Timothy L. Tickle, Sara Napolitano, Mei-Ju Su, Anand G. Patel, Åsa Karlström, Simon Gritsch, Masashi Nomura, Avinash Waghray, Satyen H. Gohil, Alexander M. Tsankov, Livnat Jerby‐Arnon, Ofir Cohen, Johanna Klughammer, Yanay Rosen, Joshua Gould, Lan Nguyễn, Matan Hofree, Peter J. Tramontozzi, Bo Li, Catherine J. Wu, Benjamin Izar, Rizwan Haq, F. Stephen Hodi, Charles H. Yoon, Aaron N. Hata, Suzanne J. Baker, Mario L. Suvà, Raphael Bueno, Elizabeth H. Stover, Michael R. Clay, Michael A. Dyer, Natalie B. Collins, Ursula A. Matulonis, Nikhil Wagle, Bruce E. Johnson, Asaf Rotem, Orit Rozenblatt–Rosen, Aviv Regev
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
Aaron N. Hata, Jeffrey A. Engelman, Anthony C. Faber